Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting the outcome of chemotherapy for lung cancer.

Current opinion in pharmacology - 1 Aug 2006

Rosell Rafael, Cecere Fabiana, Santarpia Mariacarmela, Reguart Noemi, Taron Miquel

Abstract excerpt

Lung cancer is a worldwide problem. At the time of diagnosis, 50% of patients have advanced incurable disease. Different chemotherapy combinations--with or without targeted therapies--yield similar results despite the continuous efforts of clinicians. However, molecular biological studies have al...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 Proteins
Share to DNA Repair Enzymes
Share to Erlotinib Hydrochloride

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gefitinib

Share to Mesoderm

Share to Quinazolines

Share to Thioredoxins

Share to Y-Box-Binding Protein 1

Source

Identifiers

PMID: 16765644
DOI: 10.1016/j.coph.2006.01.011

Genes

BRCA1
ERCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16765644-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting the outcome of chemotherapy for lung cancer.PMID 16765644Read ↗

From the bench to the bed: individualizing treatment in non-small-cell lung cancer.Semantic proximity Read ↗

Usefulness of predictive tests for cancer treatment.Semantic proximity Read ↗

Molecular Predictors of Response to Chemotherapy in Non-Small Cell Lung CancerSemantic proximity Read ↗

Predictors of biomarkers guiding targeted therapeutic strategies in locally advanced lung cancer.Semantic proximity Read ↗

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patientsSemantic proximity Read ↗

The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.Semantic proximity Read ↗

How could pharmacogenomics help improve patient survival?Semantic proximity Read ↗

Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based ChemotherapySemantic proximity Read ↗

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.Semantic proximity Read ↗

Prognostic and predictive biomarkers in lung cancer. A review.Semantic proximity Read ↗

Biomarkers in lung oncology.Semantic proximity Read ↗

The prognostic role of circulating DNA markers in patients with lung malignancies: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.